Representative Mikie Sherrill (D-NJ) has introduced a bill that would require Elon Musk and employees of the Department of Government Efficiency (DOGE) to undergo drug testing. This legislation mandates that these individuals pass a drug test and participate in random drug testing to maintain their special government employee status.
Meanwhile, in Virginia, lawmakers have upheld Governor Glenn Youngkin’s (R) vetoes of several key marijuana bills. These vetoes included legislation aimed at legalizing recreational marijuana sales, providing resentencing relief for individuals with past convictions, and protecting the parental rights of cannabis consumers. However, lawmakers did reject some of the governor’s proposed amendments to a medical cannabis bill that sought to limit delivery options for patients.
In Ohio, the House Judiciary Committee recently held a hearing on a bill that seeks to amend the state’s voter-approved marijuana legalization law. The committee adopted an amendment that would implement additional changes related to equity, licensing, and the distribution of tax revenue.
A recent poll in Pennsylvania revealed that voters prefer a model of legal marijuana sales that involves licensed private businesses, similar to practices in other states. This contrasts with proposals for a system of state-run cannabis stores, which some lawmakers have suggested.
Additionally, a study focusing on patients with atopic dermatitis, commonly known as eczema, found that topical treatments containing cannabidiol and cannabigerol are effective in reducing itching and improving patients’ quality of life. Researchers reported that these treatments led to symptom remission in some cases.
In Nebraska, attorneys representing the Nebraska Medical Cannabis Commission and the campaign behind the state’s medical marijuana initiatives have filed court briefs responding to a lawsuit from a former Republican senator. They described the lawsuit as “meritless” and noted that it attempts to create a “false conflict.”
On the federal level, the Drug Enforcement Administration Museum recently posted a video featuring an opium pipe from its collection. Representative Morgan Luttrell (R-TX) expressed his enthusiasm on Twitter regarding the acknowledgment of psychedelics as potential treatments for veterans, urging Congress to act to eliminate obstacles for these therapies.
In Massachusetts, Governor Maura Healey (D) has announced appointments to a new working group focused on alternative therapies involving psychedelics for veterans. Meanwhile, the Minnesota House Commerce Finance and Policy Committee has approved an omnibus cannabis bill.
Delaware lawmakers are working to resolve a dispute regarding fingerprinting background checks with the Federal Bureau of Investigation, which could delay the launch of the state’s recreational marijuana market. In Pennsylvania, a senator is preparing to introduce legislation to establish a Cannabis Control Board responsible for overseeing the medical marijuana program and currently unregulated cannabis products.
Lastly, Missouri regulators have published updated documents regarding marijuana product recalls, while Nevada regulators have issued guidance on how to determine the fair market value of wholesale cannabis. Arizona officials have also released guidance concerning marijuana tax rates, and New York’s acting marijuana regulator has indicated that the state could generate $1.5 billion in legal cannabis sales.
English 
Spanish 
German 
Czech